JP2019517586A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019517586A5 JP2019517586A5 JP2019516085A JP2019516085A JP2019517586A5 JP 2019517586 A5 JP2019517586 A5 JP 2019517586A5 JP 2019516085 A JP2019516085 A JP 2019516085A JP 2019516085 A JP2019516085 A JP 2019516085A JP 2019517586 A5 JP2019517586 A5 JP 2019517586A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- release composition
- sustained release
- poly
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002632 kappa opiate receptor agonist Substances 0.000 claims description 9
- 208000002193 Pain Diseases 0.000 claims description 5
- 229940126470 kappa opioid receptor agonist Drugs 0.000 claims description 2
- 230000002093 peripheral effect Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 25
- -1 poly(vinyl alcohol) Polymers 0.000 claims 21
- 238000013268 sustained release Methods 0.000 claims 20
- 239000012730 sustained-release form Substances 0.000 claims 20
- 150000001875 compounds Chemical class 0.000 claims 15
- 125000006726 (C1-C5) alkenyl group Chemical group 0.000 claims 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 6
- 125000003107 substituted aryl group Chemical group 0.000 claims 6
- 229920000249 biocompatible polymer Polymers 0.000 claims 5
- 239000011159 matrix material Substances 0.000 claims 5
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 4
- 229920000747 poly(lactic acid) Polymers 0.000 claims 4
- 229920001577 copolymer Polymers 0.000 claims 3
- 239000005038 ethylene vinyl acetate Substances 0.000 claims 3
- 208000000094 Chronic Pain Diseases 0.000 claims 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 2
- 239000004952 Polyamide Substances 0.000 claims 2
- 150000005215 alkyl ethers Chemical class 0.000 claims 2
- 229920002301 cellulose acetate Polymers 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 claims 2
- 229920001484 poly(alkylene) Polymers 0.000 claims 2
- 229920002627 poly(phosphazenes) Polymers 0.000 claims 2
- 229920002285 poly(styrene-co-acrylonitrile) Polymers 0.000 claims 2
- 229920002492 poly(sulfone) Polymers 0.000 claims 2
- 229920002647 polyamide Polymers 0.000 claims 2
- 229920000515 polycarbonate Polymers 0.000 claims 2
- 239000004417 polycarbonate Substances 0.000 claims 2
- 229920000139 polyethylene terephthalate Polymers 0.000 claims 2
- 239000005020 polyethylene terephthalate Substances 0.000 claims 2
- 229920002643 polyglutamic acid Polymers 0.000 claims 2
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 claims 2
- 229920000098 polyolefin Polymers 0.000 claims 2
- 229920002635 polyurethane Polymers 0.000 claims 2
- 239000004814 polyurethane Substances 0.000 claims 2
- 229920002689 polyvinyl acetate Polymers 0.000 claims 2
- 239000011118 polyvinyl acetate Substances 0.000 claims 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 2
- 229920000915 polyvinyl chloride Polymers 0.000 claims 2
- 239000004800 polyvinyl chloride Substances 0.000 claims 2
- 229920002620 polyvinyl fluoride Polymers 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 229920002554 vinyl polymer Polymers 0.000 claims 2
- 206010002383 Angina Pectoris Diseases 0.000 claims 1
- 208000036487 Arthropathies Diseases 0.000 claims 1
- 208000008035 Back Pain Diseases 0.000 claims 1
- 206010006002 Bone pain Diseases 0.000 claims 1
- 206010058019 Cancer Pain Diseases 0.000 claims 1
- 206010008479 Chest Pain Diseases 0.000 claims 1
- 208000001640 Fibromyalgia Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 206010065390 Inflammatory pain Diseases 0.000 claims 1
- 208000005615 Interstitial Cystitis Diseases 0.000 claims 1
- 208000012659 Joint disease Diseases 0.000 claims 1
- 208000008930 Low Back Pain Diseases 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 229940127450 Opioid Agonists Drugs 0.000 claims 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 claims 1
- 101100244562 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) oprD gene Proteins 0.000 claims 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 239000000556 agonist Substances 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 claims 1
- 108700023159 delta Opioid Receptors Proteins 0.000 claims 1
- 102000048124 delta Opioid Receptors Human genes 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 210000004392 genitalia Anatomy 0.000 claims 1
- 230000009610 hypersensitivity Effects 0.000 claims 1
- 239000007943 implant Substances 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 102000048260 kappa Opioid Receptors Human genes 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 102000051367 mu Opioid Receptors Human genes 0.000 claims 1
- 208000004296 neuralgia Diseases 0.000 claims 1
- 208000021722 neuropathic pain Diseases 0.000 claims 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 206010044652 trigeminal neuralgia Diseases 0.000 claims 1
- 208000009935 visceral pain Diseases 0.000 claims 1
- 108020001588 κ-opioid receptors Proteins 0.000 claims 1
- 108020001612 μ-opioid receptors Proteins 0.000 claims 1
- 0 C*C1NC1* Chemical compound C*C1NC1* 0.000 description 2
- 230000008685 targeting Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662345583P | 2016-06-03 | 2016-06-03 | |
| US62/345,583 | 2016-06-03 | ||
| PCT/US2017/035874 WO2017210668A1 (en) | 2016-06-03 | 2017-06-05 | Sustained release compositions of kappa-opioid receptor agonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019517586A JP2019517586A (ja) | 2019-06-24 |
| JP2019517586A5 true JP2019517586A5 (enExample) | 2020-07-27 |
Family
ID=60478002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019516085A Pending JP2019517586A (ja) | 2016-06-03 | 2017-06-05 | カッパオピオイド受容体アゴニストの持続放出組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20200316159A1 (enExample) |
| EP (1) | EP3463306A4 (enExample) |
| JP (1) | JP2019517586A (enExample) |
| CN (1) | CN109789094A (enExample) |
| WO (1) | WO2017210668A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3803866A4 (en) | 2018-05-24 | 2022-03-16 | Nureva Inc. | METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS |
| US11690806B2 (en) | 2018-05-24 | 2023-07-04 | Celanese Eva Performance Polymers Llc | Implantable device for sustained release of a macromolecular drug compound |
| AU2019275406B2 (en) | 2018-05-24 | 2024-11-14 | Celanese Eva Performance Polymers Llc | Implantable device for sustained release of a macromolecular drug compound |
| WO2021026492A1 (en) | 2019-08-07 | 2021-02-11 | Humanwell Pharmaceutical US | Kappa opioid receptor peptide amide agonists |
| AU2021236662A1 (en) * | 2020-03-18 | 2022-11-10 | Cara Therapeutics, Inc. | Oligosaccharide formulations of kappa opioid receptor agonists |
| AU2020454871A1 (en) | 2020-06-25 | 2023-01-19 | Humanwell Pharmaceutical US | Peptides for treatment of medical disorders |
| US20240226226A1 (en) * | 2021-04-14 | 2024-07-11 | Titan Pharmaceuticals, Inc. | Kappa-opioid receptor agonist implants for treatment of pruritus |
| BR112023022439A2 (pt) | 2021-04-26 | 2023-12-26 | Celanese Eva Performance Polymers Llc | Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular |
| CN114873741B (zh) * | 2022-05-31 | 2023-03-14 | 南京大学 | 一种脱氮缓释碳源材料及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2561860T3 (en) * | 2002-05-31 | 2018-04-30 | Titan Pharmaceuticals Inc | Implantable polymer device for prolonged release of buprenorphine |
| JP2009538310A (ja) * | 2006-05-26 | 2009-11-05 | カラ セラピューティクス インコーポレイテッド | 哺乳動物におけるプロラクチンを上昇させる方法 |
| US7842662B2 (en) * | 2006-11-10 | 2010-11-30 | Cara Therapeutics, Inc. | Synthetic peptide amide dimers |
| CA2667155C (en) * | 2006-11-10 | 2016-05-10 | Cara Therapeutics, Inc. | Synthetic peptide amides |
| JP5877640B2 (ja) * | 2007-05-01 | 2016-03-08 | フンダサオ・デ・アムパロ・ア・ペスキーサ・ド・エスタド・デ・サン・パウロ−エフイ・ア・ペー・エ・エシ・ペー | 鎮痛化合物 |
| KR20130097201A (ko) * | 2010-09-02 | 2013-09-02 | 그뤼넨탈 게엠베하 | 음이온성 중합체를 포함하는 내변조성 투여형 |
| EP3287172A1 (en) * | 2012-12-06 | 2018-02-28 | Stealth Peptides International, Inc. | Combinations of peptide therapeutics and methods for using same |
-
2017
- 2017-06-05 WO PCT/US2017/035874 patent/WO2017210668A1/en not_active Ceased
- 2017-06-05 CN CN201780045316.4A patent/CN109789094A/zh active Pending
- 2017-06-05 EP EP17807647.7A patent/EP3463306A4/en not_active Withdrawn
- 2017-06-05 JP JP2019516085A patent/JP2019517586A/ja active Pending
- 2017-06-05 US US16/305,209 patent/US20200316159A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019517586A5 (enExample) | ||
| JP2012525393A5 (enExample) | ||
| RU2428985C2 (ru) | Лекарственная форма, содержащая оксикодон и налоксон | |
| US11058638B2 (en) | Tyrosine derivatives and compositions comprising them | |
| RU2014111069A (ru) | Лекарственные формы ингибитора гистондиацетилазы в комбинации с бендамутином и их применение | |
| JP2017518334A5 (enExample) | ||
| RU2012141951A (ru) | Курс лечения с использованием агониста рецептора sip | |
| JP2010077141A5 (enExample) | ||
| RU2011138962A (ru) | Производные 4-изопропилфенилглюцита в качестве ингибиторов sglt1 | |
| RU2022108295A (ru) | Способы лечения ar+ рака молочной железы | |
| JP2005525369A5 (enExample) | ||
| JP2019511204A (ja) | コパンリシブバイオマーカー | |
| JP2019512003A (ja) | コパンリシブバイオマーカー | |
| KR101307650B1 (ko) | 구역에 대한 경피 방법 및 패치 | |
| US20230257471A1 (en) | Cancer treatment | |
| EP3030238A1 (en) | Methods of treating pruritic conditions mediated through histamine h-4 receptors | |
| KR20210074315A (ko) | P2x3 길항제를 사용한 소양증의 치료 | |
| JP2019052094A5 (enExample) | ||
| RU2313524C2 (ru) | МИТИЛИНДОЛЫ И МЕТИЛПИРРОЛОПИРИДИНЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ АКТИВНОСТЬЮ α-1-АДРЕНЕРГИЧЕСКИХ АГОНИСТОВ | |
| WO2020102303A1 (en) | Use of disulfiram and other compounds to treat cancers with loss of chromosome 16q and/or low expression of metallothionein proteins | |
| CN1610548A (zh) | 依贝沙坦在制备用来预防或治疗肺动脉高压的药物中的应用 | |
| CN104640538B (zh) | 包含ndga 衍生物和索拉非尼的组合物以及其在治疗癌症中的用途 | |
| JP2013505940A5 (enExample) | ||
| RU2006126828A (ru) | Антагонисты нейрокининового рецептора nk-1 для выхода из наркоза | |
| CN102762199A (zh) | 包含伪麻黄碱和左西替利嗪的口服复合组合物 |